Staff ReportsA House hearing on medical-school diversity and a new scientific review have collided in a way that should make anyone who cares about women’s health sit up straight. Medical leaders stumbled over language about “pregnant people” while a peer‑reviewed systematic review raised red flags about miscarriage rates in transmasculine pregnancies and possible links to testosterone exposure. This isn’t merely a word fight — it’s about patient safety, honest science, and whether ideology will outweigh caution in medicine.
New study spotlights miscarriage signal in transmasculine pregnancy
A quantitative systematic review published in a leading obstetrics journal pooled 44 studies on transmasculine pregnancy and found something that deserves attention: several small studies reported miscarriage rates much higher than typical background estimates. Some reports showed miscarriage rates on the order of roughly 30–40 percent in the samples studied, compared with commonly cited background ranges closer to 11–22 percent for cisgender women. The authors concluded the miscarriage findings “warrant further investigation” and called for better data and stronger, prospective research.
Limits of the evidence — but still a clear warning light
Before anyone treats this review as a smoking gun, a key point: the paper’s authors themselves flagged big limitations. The studies were small, often uncontrolled, inconsistent in how they measured testosterone exposure or pregnancy outcomes, and prone to selection and reporting bias. That means the review cannot prove testosterone causes miscarriage. Still, the pattern in multiple studies is worrying enough that doctors and policymakers should not shrug it off. Major clinical bodies already warn that testosterone is not reliable contraception and that exposure in early pregnancy may be risky — standard precautions that should guide care today.
Congressional hearing exposed the costs of jargon over clarity
At a recent House hearing on diversity, equity and inclusion in medical schools, Republican members pressed medical‑school leaders about whether “men” can get pregnant. UCSF Chancellor Sam Hawgood and others stuck to inclusive language like “pregnant people” and emphasized training to care for diverse patients. Fine. Compassion in care is fine. But when language becomes armor for avoiding biological realities and for sidestepping hard safety questions, it does real harm. If a new body of science suggests reproductive risk tied to hormone exposure, doctors must be blunt and specific with patients — not hide behind euphemism.
What should change: research, clear counseling, and common sense
First, fund and require better research: prospective, comparative studies and registries that record timing and dose of hormones, fertility history, and pregnancy outcomes. Second, clinical guidance must stay rooted in safety: patients of reproductive potential should receive clear counseling that testosterone is not contraception and that pregnancy while exposed to androgens raises plausible risks. Third, medical education can be both inclusive and honest — teach students to use respectful language without softening or erasing biological facts that affect care. Policymakers and hospital leaders should prioritize patient safety over ideological points.
We can be compassionate and we can be scientific. We should demand both. When studies flash warning signs about miscarriage, and when medical leaders duck clear answers in public forums, the safe bet is to protect women and pregnancies while the science catches up — not to let woke language outrun common sense.
